vs

Side-by-side financial comparison of IMMUCELL CORP (ICCC) and Kentucky First Federal Bancorp (KFFB). Click either name above to swap in a different company.

IMMUCELL CORP is the larger business by last-quarter revenue ($5.5M vs $2.8M, roughly 1.9× Kentucky First Federal Bancorp). Kentucky First Federal Bancorp runs the higher net margin — 10.7% vs -2.5%, a 13.3% gap on every dollar of revenue. On growth, Kentucky First Federal Bancorp posted the faster year-over-year revenue change (28.3% vs -8.4%). Kentucky First Federal Bancorp produced more free cash flow last quarter ($-367.0K vs $-1.8M). Over the past eight quarters, Kentucky First Federal Bancorp's revenue compounded faster (24.0% CAGR vs 3.9%).

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

Kentucky First Federal Bancorp is a U.S. regional bank holding company based in Kentucky. It offers retail and commercial banking services including deposits, mortgage loans, consumer lending and small business financing, serving local individual customers and small-to-medium enterprises across its Kentucky operating regions.

ICCC vs KFFB — Head-to-Head

Bigger by revenue
ICCC
ICCC
1.9× larger
ICCC
$5.5M
$2.8M
KFFB
Growing faster (revenue YoY)
KFFB
KFFB
+36.7% gap
KFFB
28.3%
-8.4%
ICCC
Higher net margin
KFFB
KFFB
13.3% more per $
KFFB
10.7%
-2.5%
ICCC
More free cash flow
KFFB
KFFB
$1.4M more FCF
KFFB
$-367.0K
$-1.8M
ICCC
Faster 2-yr revenue CAGR
KFFB
KFFB
Annualised
KFFB
24.0%
3.9%
ICCC

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
ICCC
ICCC
KFFB
KFFB
Revenue
$5.5M
$2.8M
Net Profit
$-139.7K
$304.0K
Gross Margin
42.9%
Operating Margin
0.4%
14.1%
Net Margin
-2.5%
10.7%
Revenue YoY
-8.4%
28.3%
Net Profit YoY
80.1%
2238.5%
EPS (diluted)
$-0.02
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICCC
ICCC
KFFB
KFFB
Q4 25
$2.8M
Q3 25
$5.5M
$2.7M
Q2 25
$6.4M
$2.4M
Q1 25
$8.1M
$2.2M
Q4 24
$7.8M
$2.2M
Q3 24
$6.0M
$2.0M
Q2 24
$5.5M
$2.0M
Q1 24
$7.3M
$1.8M
Net Profit
ICCC
ICCC
KFFB
KFFB
Q4 25
$304.0K
Q3 25
$-139.7K
$344.0K
Q2 25
$501.9K
$176.0K
Q1 25
$1.4M
$7.0K
Q4 24
$13.0K
Q3 24
$-701.7K
$-15.0K
Q2 24
$-1.5M
$-1.1M
Q1 24
$-437.9K
$-107.0K
Gross Margin
ICCC
ICCC
KFFB
KFFB
Q4 25
Q3 25
42.9%
Q2 25
43.7%
Q1 25
41.6%
Q4 24
36.5%
Q3 24
26.3%
Q2 24
22.5%
Q1 24
31.6%
Operating Margin
ICCC
ICCC
KFFB
KFFB
Q4 25
14.1%
Q3 25
0.4%
17.0%
Q2 25
8.8%
10.3%
Q1 25
13.9%
0.7%
Q4 24
8.0%
0.3%
Q3 24
-9.6%
-1.0%
Q2 24
-25.3%
-58.7%
Q1 24
-4.1%
-7.9%
Net Margin
ICCC
ICCC
KFFB
KFFB
Q4 25
10.7%
Q3 25
-2.5%
12.9%
Q2 25
7.8%
7.6%
Q1 25
17.9%
0.3%
Q4 24
0.6%
Q3 24
-11.7%
-0.7%
Q2 24
-28.0%
-56.7%
Q1 24
-6.0%
-5.8%
EPS (diluted)
ICCC
ICCC
KFFB
KFFB
Q4 25
$0.04
Q3 25
$-0.02
$0.04
Q2 25
$0.06
$0.02
Q1 25
$0.16
$0.00
Q4 24
$0.09
$0.00
Q3 24
$-0.09
$0.00
Q2 24
$-0.20
$-0.13
Q1 24
$-0.06
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICCC
ICCC
KFFB
KFFB
Cash + ST InvestmentsLiquidity on hand
$3.9M
$19.7M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$29.8M
$49.1M
Total Assets
$45.7M
$375.3M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICCC
ICCC
KFFB
KFFB
Q4 25
$19.7M
Q3 25
$3.9M
$14.6M
Q2 25
$19.5M
Q1 25
$27.8M
Q4 24
$3.8M
$21.0M
Q3 24
$17.3M
Q2 24
$1.3M
$18.3M
Q1 24
$960.3K
$15.4M
Total Debt
ICCC
ICCC
KFFB
KFFB
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
ICCC
ICCC
KFFB
KFFB
Q4 25
$49.1M
Q3 25
$29.8M
$48.8M
Q2 25
$29.9M
$48.4M
Q1 25
$29.0M
$48.2M
Q4 24
$27.5M
$48.1M
Q3 24
$26.4M
$48.2M
Q2 24
$23.5M
$48.0M
Q1 24
$24.6M
$49.0M
Total Assets
ICCC
ICCC
KFFB
KFFB
Q4 25
$375.3M
Q3 25
$45.7M
$366.5M
Q2 25
$46.7M
$371.2M
Q1 25
$45.6M
$380.7M
Q4 24
$45.1M
$374.2M
Q3 24
$44.4M
$375.6M
Q2 24
$41.9M
$375.0M
Q1 24
$43.1M
$369.1M
Debt / Equity
ICCC
ICCC
KFFB
KFFB
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICCC
ICCC
KFFB
KFFB
Operating Cash FlowLast quarter
$-1.2M
$-303.0K
Free Cash FlowOCF − Capex
$-1.8M
$-367.0K
FCF MarginFCF / Revenue
-32.3%
-12.9%
Capex IntensityCapex / Revenue
10.8%
2.3%
Cash ConversionOCF / Net Profit
-1.00×
TTM Free Cash FlowTrailing 4 quarters
$715.4K
$-377.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICCC
ICCC
KFFB
KFFB
Q4 25
$-303.0K
Q3 25
$-1.2M
$450.0K
Q2 25
$1.6M
$-86.0K
Q1 25
$1.6M
$-155.0K
Q4 24
$-3.1K
$1.4M
Q3 24
$-639.3K
$-1.4M
Q2 24
$581.8K
$-1.5M
Q1 24
$418.5K
$-176.0K
Free Cash Flow
ICCC
ICCC
KFFB
KFFB
Q4 25
$-367.0K
Q3 25
$-1.8M
$445.0K
Q2 25
$1.4M
$-235.0K
Q1 25
$1.2M
$-220.0K
Q4 24
$-199.3K
$1.4M
Q3 24
$-727.7K
$-1.4M
Q2 24
$471.0K
$-1.5M
Q1 24
$348.1K
$-191.0K
FCF Margin
ICCC
ICCC
KFFB
KFFB
Q4 25
-12.9%
Q3 25
-32.3%
16.7%
Q2 25
22.4%
-9.7%
Q1 25
15.4%
-9.9%
Q4 24
-2.6%
61.8%
Q3 24
-12.1%
-70.2%
Q2 24
8.6%
-77.7%
Q1 24
4.8%
-10.4%
Capex Intensity
ICCC
ICCC
KFFB
KFFB
Q4 25
2.3%
Q3 25
10.8%
0.2%
Q2 25
2.4%
6.2%
Q1 25
4.1%
2.9%
Q4 24
2.5%
3.7%
Q3 24
1.5%
0.1%
Q2 24
2.0%
3.4%
Q1 24
1.0%
0.8%
Cash Conversion
ICCC
ICCC
KFFB
KFFB
Q4 25
-1.00×
Q3 25
1.31×
Q2 25
3.19×
-0.49×
Q1 25
1.09×
-22.14×
Q4 24
111.31×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons